Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Ovarian Neoplasms 1 Fallopian Tube Neoplasms 1 Endometrial Neoplasms 1 Breast Neoplasms 1

Interventions

Fulvestrant 36 Specimen Handling 32 Letrozole 32 Paclitaxel 24 pembrolizumab 19 Carboplatin 19 Capecitabine 19 ribociclib 18 exemestane 18 palbociclib 17 Trastuzumab 17 Tamoxifen 17 Magnetic Resonance Spectroscopy 17 Anastrozole 16 Biopsy 15 trastuzumab deruxtecan 14 abemaciclib 14 pertuzumab 11 Radiotherapy 11 Cyclophosphamide 9 inavolisib 8 elacestrant 8 olaparib 7 Taxes 7 Standard of Care 7 Radiation 7 Mastectomy, Segmental 7 Goserelin 7 130-nm albumin-bound paclitaxel 7 giredestrant 6

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Breast Neoplasms × Biosimilar Pharmaceuticals × 30 days × Clear all

NCT07220135 2026-05-06

NeoTHERa

University of Kansas Medical Center

Phase 2 Recruiting

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡